Similar articles

• A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.

  Merideth CH, Feighner JP, Hendrickson G. Merideth CH, et al. J Clin Psychiatry. 1984 Apr;45(4 Pt 2):73-7. J Clin Psychiatry. 1984. PMID: 6370981 Clinical Trial.
• Nomifensine, imipramine and placebo in depressed outpatients.

  Rickels K, Weise CC, Sandler K, Schless A, Zal M, Norstad N. Rickels K, et al. Int Pharmacopsychiatry. 1982;17 Suppl 1:73-88. doi: 10.1159/000468602. Int Pharmacopsychiatry. 1982. PMID: 6752080 Clinical Trial. No abstract available.
• Multicenter double-blind comparison of nomifensine and imipramine for efficacy and safety in depressed outpatients.

  Bremner JD, Abrahams LM, Crupie JE, McCawley A, Proctor RC, Sathananthan GL. Bremner JD, et al. J Clin Psychiatry. 1984 Apr;45(4 Pt 2):56-9. J Clin Psychiatry. 1984. PMID: 6370976 Clinical Trial.
• A review of controlled studies with nomifensine, performed outside the UK.

  Habermann W. Habermann W. Br J Clin Pharmacol. 1977;4Suppl 2(Suppl 2):237S-241S. doi: 10.1111/j.1365-2125.1977.tb05759.x. Br J Clin Pharmacol. 1977. PMID: 334230 Free PMC article. Review.
• [Nomifensine: clinical data (author's transl)].

  Clerc G, Cayreyre M. Clerc G, et al. Nouv Presse Med. 1978 Jun 28;7(26):2295-304. Nouv Presse Med. 1978. PMID: 353720 Review. French.